Although ctDNA positivity generally meant worse disease-free survival in stage 3 resected colon cancer, patients with ctDNA ...
Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefitted from first-line treatment with ...
Unlocking the Secrets of Cancer Metastasis: Study Provides New Insights ... Diet Is Main Risk Factor for Colon Cancer in Younger Adults, New Study Suggests Aug. 14, 2024 — A new study has ...
Fuck cancer. I mean, I usually don’t know what else to say when a contact reaches out to tell me that another metal artist is ...
Researchers have discovered how a particular protein affects the growth and spread of colon cancer in humans. The study not ...
Bristol Myers Squibb (BMS) has shared promising results from a late-stage study of its dual immunotherapy combination in ...
New data from two studies presented at ASCO GI 2025 demonstrated that ctDNA testing could predict recurrence risk in early-stage colorectal cancer.
The combination of Opdivo and Yervoy is supported by updated results as a standard of care for MSI-H or dMMR metastatic ...
Agenus (AGEN) presented multiple posters and presentations for botensilimab and balstilimab across various treatment lines of colon and ...
Agenus (AGEN) announced publication in the Journal of Clinical Oncology showcasing data from its study of botensilimab in combination with ...
The Phase III trial builds on findings from prior findings that indicated Anktiva can restore T-cell function and improve overall survival in patients with advanced of metastatic non-small cell lung ...